![Qing Bei Zeng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 3 M $ as of 31/08/2026
Qing Bei Zeng has been serving as Chief Scientist, Senior VP & Deputy GM at Dizal (Jiangsu) Pharmaceutical Co., Ltd. since 2017.
Dr. Zeng holds a doctorate degree from The Ohio State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/12/2025 | 252,000 ( 0.09% ) | 2 M $ | 31/08/2026 | |
| 16/12/2025 | 110,000 ( 0.02% ) | 954 009 $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Chief Tech/Sci/R&D Officer | 01/12/2017 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
 Dizal (Jiangsu) Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
